Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154441 | SCV000204110 | uncertain significance | not specified | 2016-02-11 | criteria provided, single submitter | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
Invitae | RCV000229273 | SCV000288620 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-12-23 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000229273 | SCV000475612 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000328066 | SCV000475613 | likely benign | Loeys-Dietz syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000384899 | SCV000475614 | likely benign | Loeys-Dietz syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000766901 | SCV000514886 | likely benign | not provided | 2020-11-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24793577) |
Ambry Genetics | RCV000229273 | SCV000739750 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000229273 | SCV000782356 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154441 | SCV000918307 | likely benign | not specified | 2017-10-13 | criteria provided, single submitter | clinical testing | Variant summary: The c.415A>G (p.Ile139Val) in TGFBR1 gene is a missense change that involves the alteration of a non- conserved nucleotide and 5/4 in silico tools predict benign outcome. The variant was observed in the control datasets of the ExAC and gnomAD at a frequency of 0.00025 (24/121346 and 62/245812 chrs tested, including 1 homozygote). The observed frequency exceeds the maximal expected allele frequency for a pathogenic variant in this gene (0.000002). The variant has been identified in 1 individual with suspected MSF/LDS or TAAD, without strong evidence for causality (Lerner-Ellis_2014). In addition, one clinical laboratory reports co-occurrence of this variant with unspecified pathogenic cardiogenetic variant with disclosure that segregation analysis was not performed. Although several reputable databases/diagnostic centers classified the variant of interest as VUS/Likely Benign, by applying ACMG rules the variant was classified as Likely Benign. |
Color Diagnostics, |
RCV000229273 | SCV001345186 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000766901 | SCV001500556 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | TGFBR1: BP4, BS2 |